REGENEREX PHARMA, INC. Stock-Based Compensation
REGENEREX PHARMA, INC. reported Stock-Based Compensation of $994.71 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-31
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $559.71K, a 3014.18% increase year-over-year.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $177.87K, a 396.86% increase year-over-year.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $257.13K, a 1124.62% increase year-over-year.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $57.89K, a 1.45% increase year-over-year.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $132.66K, a 37.33% decline from fiscal 2024.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $211.70K.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $45.00K.
- REGENEREX PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $45.00K, a 339.02% increase from fiscal 2018.
| Period end | Share-based Payment Arrangement, Noncash Expense 1 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $559.71K derived: 10-KT 9 month − 10-Q 6 month · filed 2026-08-31 | $737.58K derived: sum of 2 quarters · filed 2026-08-31 | $994.71K 10-KT · filed 2026-08-31 | $1.05M derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-09-30 | $177.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-17 | $435.00K 10-Q · filed 2025-11-17 | $492.89K derived: sum of 3 quarters · filed 2026-08-31 | $510.87K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-06-30 | $257.13K 10-Q · filed 2025-08-14 | $315.03K derived: sum of 2 quarters · filed 2026-08-31 | $333.00K derived: sum of 3 quarters · filed 2026-08-31 | $368.80K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-03-31 | $57.89K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-08-31 | $75.87K derived: sum of 2 quarters · filed 2026-08-31 | $111.67K derived: sum of 3 quarters · filed 2026-08-31 | $132.66K 10-KT · filed 2026-08-31 | |
| 2024-12-31 | $17.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $53.77K derived: sum of 2 quarters · filed 2025-11-17 | $74.77K 10-Q · filed 2025-02-07 | $131.83K derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-09-30 | $35.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-17 | $56.80K 10-Q · filed 2025-11-17 | $113.86K derived: sum of 3 quarters · filed 2025-11-17 | $135.10K derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-06-30 | $21.00K 10-Q · filed 2025-08-14 | $78.06K derived: sum of 2 quarters · filed 2025-08-14 | $99.31K derived: sum of 3 quarters · filed 2025-08-14 | $198.14K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $57.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | $78.31K derived: sum of 2 quarters · filed 2025-06-30 | $177.14K derived: sum of 3 quarters · filed 2025-06-30 | $211.70K 10-K · filed 2025-06-30 | |
| 2023-12-31 | $21.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $120.08K derived: sum of 2 quarters · filed 2025-02-07 | $154.63K 10-Q · filed 2025-02-07 | ||
| 2023-09-30 | $98.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-04 | $133.39K 10-Q · filed 2024-11-04 | |||
| 2023-06-30 | $34.55K 10-Q · filed 2024-08-07 | ||||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-09 | $45.00K 10-K · filed 2023-06-09 | |||
| 2021-12-31 | $45.00K 10-Q · filed 2023-01-24 | ||||
| 2019-03-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-11 | $45.00K 10-K/A · filed 2020-08-11 | |||
| 2018-12-31 | $45.00K 10-K/A · filed 2020-08-11 | $45.00K 10-Q · filed 2020-02-10 | |||
| 2018-03-31 | $10.25K 10-K · filed 2019-06-24 |